Milgamma compositum Tablets n / o, # 30

Round, biconvex, white film-coated tablets.

Name ENG

MILGAMMA COMPOSITUM

Clinical and pharmacological group

B complex vitamins

ATX code

Combination of vitamin B1 with vitamins B6 and / or B12

Dosage

100mg + 100mg

Structure

1 coated tablet contains:

active substances: benfotiamine 100 mg,

pyridoxine hydrochloride 100 mg.

Excipients:

composition of the coated tablet core: microcrystalline cellulose - 222.0 mg, povidone (K value = 30) - 8.0 mg, high-chain partial glycerides - 5.0 mg, colloidal silicon dioxide - 7.0 mg, croscarmellose sodium - 3.0 mg, talc - 5.0 mg

shell composition:

shellac 37% on a dry matter basis - 3.0 mg, sucrose - 92.399 mg, calcium carbonate - 91.675 mg, talc - 55.130 mg, acacia gum - 14.144 mg, corn starch - 10.230 mg, titanium dioxide (E 171) - 14.362 mg, colloidal silicon dioxide - 6.138 mg, povidone (K value = 30) - 7.865 mg, macrogol-6000 - 2.023 mg, glycerol 85% in terms of dry matter - 2.865 mg, polysorbate-80 - 0.169 mg, mountain wax glycol - 0.120 mg

Indications

Neurological diseases with confirmed deficiency of vitamins B1 and B6.

Contraindications

Hypersensitivity to thiamine, benfotiamine, pyridoxine or other components of the drug.

The period of pregnancy and breastfeeding.

(See section Use during pregnancy and breastfeeding").

Childhood due to lack of data.

Each tablet contains 92.4 mg sucrose.

Therefore, the drug should not be used by persons with congenital fructose intolerance, glucose-galactose malabsorption syndrome or glucose-isomaltase deficiency.

If you have any of the listed diseases, be sure to consult your doctor before taking this medicine.

Application during pregnancy and during breastfeeding:

use of the drug is contraindicated during pregnancy and breastfeeding.

(See section "Contraindications").

INN / Active ingredient

Benfotiamine, Pyridoxine

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 5 years

Specifications

Category

Neurological disorders

Scope of the drug

Neurology, psychiatry

Release form

Tablet

Manufacturer country

Germany

Package quantity, pcs

thirty

Scope of application

Neurology

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

ToExternalID_146958738

The amount of the dosage form in the primary package

15 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

B vitamins

Dosage form

Film-coated tablets

Packaging

Box

Dosage (volume) of the substance in the preparation

1 tablet: benfotiamine 100 mg, pyridoxine 100 mg

The target audience

Adult

Expiration date in days

1825

Package weight, g

thirty

Mode of application

:

Inside.

The tablet should be taken with plenty of liquid.

Unless otherwise prescribed by the attending physician, an adult patient should take 1 tablet per day.

In acute cases, after consulting a doctor, the dose may be increased to 1 tablet 3 times a day.

After 4 weeks of treatment, the doctor must decide whether to continue taking the drug in an increased dose and consider reducing the increased dose of vitamins B6 and B1 to 1 tablet per day.

If possible, the dose should be reduced to 1 tablet per day in order to reduce the risk of neuropathy associated with the use of vitamin B6.

Anatomical and therapeutic characteristics

:

A11DB Vitamin B1 in combination with vitamin B6 and / or vitamin B12

"